Thomas Flaten Analyst PerformanceSenior Research Analyst at Lake Street CapitalThomas Flaten is a stock analyst at Lake Street Capital focused in the medical sector, covering 18 publicly traded companies. Over the past year, Thomas Flaten has issued 18 stock ratings, including buy and hold recommendations. While full access to Thomas Flaten's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Thomas Flaten's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 6 YearsBuy Recommendations88.00% 22 Buy RatingsCompanies Covered18 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Thomas Flaten.RatingPercentageCount Strong Buy0.0%0 ratings Buy88.0%22 ratings Hold12.0%3 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Thomas Flaten at Lake Street Capital, the majority (88.0%) have been Buy recommendations, followed by 12.0% Hold.Best & Worst CallsBest Call000.0%VCYTDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%EVAXFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ18 companiesThomas Flaten, an analyst at Lake Street Capital, currently covers 18 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies94.4%Manufacturing1 company5.6%Thomas Flaten of Lake Street Capital specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - DRUGS4 companies22.2%MED - BIOMED/GENE4 companies22.2%MEDICAL INFO SYS2 companies11.1%MED INSTRUMENTS2 companies11.1%MEDICAL SERVICES2 companies11.1%PHARMACEUTICAL PREPARATIONS2 companies11.1%IN VITRO, IN VIVO DIAGNOSTIC SUBSTANCES1 company5.6%MED - GENERIC DRG1 company5.6% Thomas Flaten's Ratings History at Lake Street Capital Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsASRTAssertio4/9/2026Downgrade$18.03$18.00Hold$0.0000.00% ROIEVAXEvaxion A/S3/9/2026Lower Price Target$3.12$9.00Buy$0.0000.00% ROIIMDXOncocyte2/17/2026Boost Price Target$5.52$12.00Buy$0.0000.00% ROICSTLCastle Biosciences1/12/2026Boost Price Target$41.17$52.00Buy$0.0000.00% ROIDMACDiaMedica Therapeutics1/5/2026Reiterated Rating$7.93Buy$0.0000.00% ROICNTBConnect Biopharma12/1/2025Initiated Coverage$2.77$9.00Buy$0.0000.00% ROICNTBConnect Biopharma12/1/2025Initiated Coverage$2.66$9.00Buy$0.0000.00% ROIMDXHMDxHealth11/13/2025Boost Price Target$4.01$9.00Buy$0.0000.00% ROIPSNLPersonalis11/5/2025Reiterated Rating$7.58$11.00Buy$0.0000.00% ROIEVAXEvaxion A/S10/20/2025Boost Price Target$6.79$11.00Buy$0.0000.00% ROIHROWHarrow9/29/2025Boost Price Target$47.10$70.00Buy$0.0000.00% ROIDERMJourney Medical8/13/2025Boost Price Target$7.33$13.00Buy$0.0000.00% ROIRPIDRapid Micro Biosystems7/28/2025Initiated Coverage$4.08$8.00Buy$0.0000.00% ROIDMACDiaMedica Therapeutics7/18/2025Boost Price Target$3.93$14.00Buy$0.0000.00% ROIAYTUAytu BioPharma7/1/2025Initiated Coverage$2.18$8.00Buy$0.0000.00% ROIOCXOncoCyte5/21/2025Reiterated Rating$3.44$8.00Buy$0.0000.00% ROIBDSXBiodesix5/14/2025Lower Price Target$4.39$40.00Buy$0.0000.00% ROICSTLCastle Biosciences5/6/2025Lower Price Target$16.62$35.00Buy$0.0000.00% ROIOCXOncoCyte3/28/2025Initiated Coverage$3.22$5.00Buy$0.0000.00% ROIOPTNOptiNose3/20/2025Downgrade$6.00$9.00Hold$0.0000.00% ROICKPTCheckpoint Therapeutics3/10/2025Reiterated Rating$3.99$4.10Hold$0.0000.00% ROIAQSTAquestive Therapeutics3/7/2025Lower Price Target$2.65$8.00Buy$0.0000.00% ROIEVAXEvaxion A/S2/4/2025Lower Price Target$3.30$6.00Buy$0.0000.00% ROIOPTNOptiNose1/16/2025Lower Price Target$6.13$17.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenMorgan StanleyRoyal Bank Of CanadaBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
